Vote Scores

Home / Companies / 89bio, Inc. / 28 May 2025

Meeting · year to 30 June 2025264 filers reporting

89bio, Inc.: meeting of 28 May 2025

Votes reported on Form N-PX, item by item

264 Form N-PX filers reported votes at the 89bio, Inc. meeting of 28 May 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 64.6% of reported votes for; 62 filers withheld from or voted against at least one nominee.

450 vote records from 86 filers. 24 of the 86 filers that marked the item either way voted against management.

72.1% for0.0% against27.9% other27.9% against management86 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

371 vote records from 264 filers. 74 of the 255 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.

68.2% for28.0% against3.8% other29.0% against management264 filers93.9% for6.1% against0.0% other6.1% against management137,814,189 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

150 vote records from 86 filers. 0 of the 86 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management86 filers100.0% for0.0% against0.0% against management32,677,233 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *ForFor
FidelityForForFor
DimensionalAbstain or withhold *Against *For
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableAbstain or withhold *ForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganNo reportForNo report
Goldman SachsForForFor
PGIM and PrudentialAbstain or withhold *Against *For
Jackson National fundsAbstain or withhold *Against *For
Northern Trust and FlexSharesForForFor
SEIAbstain or withhold *Against *For
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaAbstain or withhold *ForFor
First TrustForForFor
NationwideAbstain or withhold *ForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
BNY MellonNo reportForNo report
PrincipalAbstain or withhold *ForFor
Pacific Life fundsAbstain or withhold *ForFor
Global XAbstain or withhold *Against *For
Federated HermesAbstain or withhold *Against *For
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
Harbor FundsForForFor
Janus HendersonForForFor
Neuberger BermanNo reportAgainst *No report
Natixis and Loomis SaylesNo reportAgainst *No report
Lord AbbettForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the 89bio, Inc. meeting?

264 Form N-PX filers reported votes at the meeting of 28 May 2025. On say-on-pay, 74 of 255 voted against management (29.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by 89bio, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for 89bio, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing 89bio, Inc. with a meeting date within three days of 28 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.